Latest Posts

Nancy Hicks's picture

Money Does Not Buy the Best Healthcare

0 comments

The old adage, “you get what you pay for” does[[wysiwyg_imageupload:126:]]
not apply to healthcare.  As noted in a Commonwealth Fund study recently released, the United States spends more on healthcare than 12 other industrialized countries – and it doesn’t seem that our care is any better.

The cost gap is substantial.  The U.S. spends nearly $8,000 per person on health services while the next most expensive countries – Norway and Switzerland – spend a little more than $5,000 per person. Read full post »

Victoria Reason's picture

More than Skin Deep - the Science of Beauty

1 comment

With a heavy cloud surrounding the safety of [[wysiwyg_imageupload:124:]]
cosmetic procedures, and many feeling uncomfortable with the perceived risks of surgery, women are increasingly turning to the next hero anti-ageing product within their budget. As a result the beauty industry will continue to invest heavily in delivering the latest breakthrough science that does not just claim, but proves to women, that this is the ‘must have’ product worth spending their hard earned cash on.  As a result we are seeing the paths of beauty and science converging more closely than ever before with a trend towards beauty companies using technologies and methods that have previously only been used at the cutting edge of pharmaceutical research, for example the use of NASA atomic force microscopes to observe molecular structures in hair. Read full post »

In: Consumer Health  /   filed under: anti-aging | Cosmetics
Raúl Torres's picture

What’s in a Name?

0 comments

Editor’s Note – this post was co-authored by [[wysiwyg_imageupload:125:]]
former Ketchum Pleon London colleague Joanna Birch.

As the glory days of Big Pharma’s monster blockbusters hurtle towards extinction taking billions of dollars, pounds and Euros profit with them, their biosimilars are preparing to pick up the lost market share. While they have invested significant time and money to develop counter attack strategies, there is one very large barrier standing in their way: generics are cheap.

As we well know, the simple truth is that in comparison to branded medications, generics will always win on price. And strategies such as incentivizing physicians in many EU countries to ensure that generics comprise a significant percentage of their prescriptions are now common practice. Read full post »

Oleg Abdurashitov's picture

What Russian Patients Think of Healthcare

1 comment

These days, healthcare discussions start with [[wysiwyg_imageupload:123:]]
figures – so here are some basic Russian statistics.

According to UN estimates the average life expectancy in Russia is only 69 years (in the US, ranked only 49th out of 200 countries, life expectancy is over 78 years). To take one example, the mortality rate of vascular diseases is 900 cases on every 100,000 people – almost three-folds that of the US, but more importantly one-third higher than in neighboring Bulgaria and twice as much as Hungary. Similar patterns are observed in oncology, trauma and even infectious diseases.  Read full post »

Sultana Ali's picture

Saving Lives Via Social Media

0 comments

Editor's Note: This post originally ran on the Ketchum Blog and can be found here. 

 

Times They Are a-Changin’! These immortal words written [[wysiwyg_imageupload:121:]]
and performed by Bob Dylan in 1964 continue to echo through our world today. Perhaps it is nowhere more present than in the world of social media in the manner of altering the way we share our personal choices, particularly when it comes to topics of health.

It is unlikely in 1968 when The Uniform Anatomical Gift Act (UAGA) provided the legal standing for organ transplantation, that people might have imagined there would someday be a national computer registry of donated organs, but that is exactly what happened in 1984 through the National Organ Transplant Act (NOTA). Eventually, states began to offer an individual the option to list “organ donor” as a status on their driver’s license; a private and personal choice declaring that if something were to happen to that person, their organs could be transplanted if determined usable. Read full post »